Ofir Levi

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ David Baker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Ofir Levi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 30,000 $20,571 $0.6857 14 May 2021 Direct

Insider Reports Filed by Ofir Levi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRI Vallon Pharmaceuticals, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 16:08